Cargando…
Correction: Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
Autores principales: | Marklund, Emelie, Leach, Susannah, Axelsson, Hannes, Nyström, Kristina, Norder, Heléne, Bemark, Mats, Angeletti, Davide, Lundgren, Anna, Nilsson, Staffan, Andersson, Lars-Magnus, Yilmaz, Aylin, Lindh, Magnus, Liljeqvist, Jan-Åke, Gisslén, Magnus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8489718/ https://www.ncbi.nlm.nih.gov/pubmed/34606511 http://dx.doi.org/10.1371/journal.pone.0258401 |
Ejemplares similares
-
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders
por: Marklund, Emelie, et al.
Publicado: (2020) -
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4(+) T-Cell Responses
por: Marklund, Emelie, et al.
Publicado: (2021) -
Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
por: Lundgren, Anna, et al.
Publicado: (2023) -
Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021) -
The antiinflammatory activity of IgG: the intravenous IgG paradox
por: Nimmerjahn, Falk, et al.
Publicado: (2007)